Department of Health and Human Services spokesperson

“Across HHS, CMS is expanding access to treatment, FDA is approving new options, HRSA is strengthening care, NIH is advancing research, and CDC is continuing surveillance that helps states identify gaps in care and treatment,”

Department of Health and Human Services spokesperson · said date not stated · reported 2026-10-16

The HHS spokesperson detailed efforts across multiple federal health agencies to address sickle cell disease care and research.

“President Trump and Secretary Kennedy have made improving care and outcomes for Americans living with sickle cell disease a top priority.”

Department of Health and Human Services spokesperson · said date not stated · reported 2026-10-16

An HHS spokesperson stated in a release that sickle cell disease care is a top priority for the Trump administration.